Permanens Capital’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$303K Hold
2,125
– – 0.03% 87
2026
Q2
$333K Buy
+2,125
New +$319K 0.03% 81
2020
Q1
– Sell
-177
Closed -$17K – 132
2019
Q4
$17K Buy
+177
New +$15.9K ﹤0.01% 101

Other funds holding NVS

Permanens Capital's NVS Position: Q3 2026 in Review

Permanens Capital held its Novartis (NVS) position steady in Q3 2026 at 2,125 shares worth $303K. The position accounts for 0.03% of the portfolio, ranked #87.

Permanens Capital first reported a position in NVS in Q4 2019 and has held it in 3 quarters since. The position peaked at $333K in Q2 2026. 1,554 funds tracked by Wall St. Rank hold NVS as of Q3 2026.

  • Permanens Capital held 2,125 shares of Novartis worth $303K as of Q3 2026.
  • Permanens Capital left its Novartis share count unchanged in Q3 2026.
  • Novartis made up 0.03% of Permanens Capital's portfolio in Q3 2026, its #87 holding.
  • Permanens Capital first reported a position in Novartis in Q4 2019 and has held it in 3 quarters since.
  • Permanens Capital's Novartis position peaked at $333K in Q2 2026.
  • 1,554 funds tracked by Wall St. Rank held Novartis as of Q3 2026.

Based on Permanens Capital's 13F filing for Q3 2026, filed 16 Nov 2026.